Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. (Record no. 19091440)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 02228 a2200673 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515183304.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201004s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1432-0428 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1007/s00125-009-1484-7 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | de Galan, B E |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20100426 |
245 00 - TITLE STATEMENT | |
Title | Cognitive function and risks of cardiovascular disease and hypoglycaemia in patients with type 2 diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) trial. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Diabetologia |
Date of publication, distribution, etc. | Nov 2009 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 2328-2336 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antihypertensive Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cognition |
General subdivision | drug effects |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Cognition Disorders |
General subdivision | complications |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetes Mellitus, Type 2 |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetic Angiopathies |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Combinations |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Drug Therapy, Combination |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Educational Status |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gliclazide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypoglycemia |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypoglycemic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Indapamide |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Mental Status Schedule |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Myocardial Infarction |
General subdivision | epidemiology |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Perindopril |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Risk Factors |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Stroke |
General subdivision | epidemiology |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Zoungas, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Chalmers, J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Anderson, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Dufouil, C |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pillai, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Cooper, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Grobbee, D E |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hackett, M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Hamet, P |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Heller, S R |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Lisheng, L |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | MacMahon, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Mancia, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Neal, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Pan, C Y |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Patel, A |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Poulter, N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Travert, F |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Woodward, M |
773 0# - HOST ITEM ENTRY | |
Title | Diabetologia |
Related parts | vol. 52 |
-- | no. 11 |
-- | p. 2328-2336 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1007/s00125-009-1484-7">https://doi.org/10.1007/s00125-009-1484-7</a> |
Public note | Available from publisher's website |
No items available.